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Eukaryotic genomes are replicated from large
numbers of replication origins distributed on
multiple chromosomes. The activity of these origins
must be coordinated so that the entire genome is
efficiently and accurately replicated yet no region
of the genome is ever replicated more than once.
The past decade has seen significant advances in
understanding how the initiation of DNA replication
is regulated by key cell-cycle regulators, including
the cyclin dependent kinases (CDKs) and the
anaphase promoting complex/cyclosome (APC/C).
The assembly of essential prereplicative complexes
(pre-RCs) at origins only occurs when CDK activity
is low and APC/C activity is high. Origin firing,
however, can only occur when the APC/C is
inactivated and CDKs become active. This two step
mechanism ensures that no origin can fire more
than once in a cell cycle. In all eukaryotes tested,
CDKs can contribute to the inhibition of pre-RC
assembly. This inhibition is characterised both by
high degrees of redundancy and evolutionary
plasticity. Geminin plays a crucial role in inhibiting
licensing in metazoans and, like cyclins, is
inactivated by the APC/C. Strategies involved in
preventing re-replication in different organisms will
be discussed.
Introduction
In all cell types, from the simplest bacteria to the
most complex multicellular organisms, precise coor-
dination of DNA replication with chromosome segre-
gation during the cell division cycle is required to
ensure that both daughter cells inherit a complete
and intact complement of genetic material. The rela-
tively large genomes of eukaryotic cells are repli-
cated from multiple replication origins on multiple
chromosomes. The evolution of a system for control-
ling multiple replication origins so they are all acti-
vated precisely once during each S phase was
undoubtedly an important step in the evolution of the
modern eukaryotic cell, because it removed a major
constraint on genome size — the amount of DNA that
can be replicated from a single replication origin. In
this review, the regulation of replication origin licens-
ing in a number of organisms will be discussed. Dif-
ferences in regulation as well as some unifying ideas
will be presented.
CDKs and APC/C: Opposing Forces in the Cell Cycle
The eukaryotic cell cycle is driven by the periodic accu-
mulation and destruction of cyclins. In Figure 1, the
temporal regulation of cyclin levels as well as some of
the essential regulators of CDK activity relevant to this
review are shown. Mitotic (M-)CDKs, which are essen-
tial for entering mitosis, activate an E3 ubiquitin ligase
called the anaphase promoting complex or cyclosome
(APC/C). The first form of APC/C to act is regulated by
a WD-40 repeat protein called Cdc20 (Figure 1A).
APC/CCdc20 is required for sister chromatid separation
and begins the process of cyclin proteolysis. Because
Cdc20 can only activate APC/C that has been hyper-
phosphorylated by M-CDK, APC/CCdc20 is believed to
promote its own inactivation (Figure 1B) by reducing
cyclin levels (Figure 1C). In many cell types, a second
form of APC/C, regulated by a related WD-40 protein,
Cdh1, becomes active after Cdc20-dependent CDK
inactivation, because Cdh1 is inhibited by direct CDK
phosphorylation (Figure 1D). APC/CCdh1 not only
contributes to cyclin proteolysis, but also targets Cdc20
for proteolysis  (Figure 1E,F), completing the inactiva-
tion of APC/CCdc20. 
APC/C activity during mitosis is regulated by several
networks (not shown in Figure 1), including the spindle
assembly checkpoint, the FEAR network (Cdc
fourteen early anaphase release) and MEN (mitotic exit
network). The latter two involve the activation of
Cdc14, a protein phosphatase which dephosphory-
lates a number of CDK substrates. During G1 phase,
CDKs are kept inactive by both APC/CCdh1 and cyclin
dependent kinase inhibitors (CKIs) (Figure 1H). G1
cyclins are generally not APC/C substrates. G1–CDK
activation at a point known as ‘START’ in yeast — the
‘restriction point’ in mammalian cells — is required to
inactivate APC/CCdh1 (Figure 1I) and to target CKIs for
ubiquitin-mediated degradation by a second E3
ubiquitin ligase called SCF (Figure 1J). Together, these
processes promote activation of the S phase (S-)CDKs
(Figure 1K). Later in the cell cycle, M-CDKs are acti-
vated and inhibit G1 cyclin transcription  (Figure 1L).
DNA replication is limited to once per cell cycle in
eukaryotic cells because the assembly of essential
pre-replication complexes (pre-RCs) at replication
origins can only occur in a window of time during the
low CDK, high APC/C period from late mitosis through
early G1 phase. Origin firing can only occur after the
APC/C has been inactivated and CDKs reaccumulate.
Thus, pre-RCs cannot assemble at origins during S,
G2 and M phases. The pre-RC assembly reaction,
known as licensing, involves the loading of the pre-
sumptive replicative helicase, the Mcm2–7 complex, in
an ATP-dependent reaction that requires the origin
recognition complex (ORC) and two essential factors,
Cdc6 and Cdt1. For a detailed discussion of the
licensing reaction see [1]. In the next section, pre-RC
regulation by CDKs and APC/C in several different
organisms will be considered.
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Budding Yeast
The cell cycle of the budding yeast Saccharomyces
cerevisiae is characterised by a relatively long and
variable G1 phase and a very short G2 phase.
Transcription and protein synthesis are required for
transit through G1 phase, and it is during G1 phase
that growth control occurs. Mating pheromone
induces a G1 arrest by preventing activation of G1-
CDKs, and cells can exit the cell cycle from G1 phase
when deprived of nutrients.
Pre-RCs can only assemble during a window of
opportunity from late mitosis through G1 phase,
because CDKs inhibit pre-RC assembly [2–4].
Inactivation of CDKs in either S- or G2/M-arrested
cells, by overexpression of the CKI Sic1 or by using a
temperature sensitive cdk1 (cdc28) mutant, drives the
reassembly of pre-RCs [3,5]. If CDKs are subsequently
reactivated in these G2-arrested cells, a complete
extra round of DNA replication occurs. CDK inactiva-
tion in G2/M can induce pre-RC assembly even when
the APC/C and MEN are inactive [5], arguing that the
only essential role for the APC/C and MEN in pre-RC
assembly is to inactivate M-CDKs.
CDKs inhibit pre-RC assembly by directly inhibiting
each pre-RC component. The Cdc6 protein accumu-
lates during early G1 phase, but is not present from
late G1 phase until the following mitosis [6,7]. Both
regulated transcription and regulated proteolysis con-
tribute to the periodic accumulation of Cdc6 protein.
Phosphorylation of Cdc6 by CDKs targets the protein
for ubiquitin-mediated proteolysis by SCFCDC4 [6–11].
SCFCDC4-dependent proteolysis of Cdc6 is especially
rapid from late G1 phase through S phase. Later in the
cell cycle, Cdc6 becomes partially stabilized but
remains inactive for pre-RC assembly [12] (S. Mimura,
T. Seki, S. Tanaka and J.D., unpublished data).
The Mcm2–7 complex enters the nucleus at the end
of mitosis, remains nuclear during G1 phase and
becomes primarily cytoplasmic later in the cell cycle.
This regulated accumulation of Mcm2–7 in the nucleus
does not require Cdc6, so is independent of the
loading of Mcm2–7 onto chromatin [13,14].
Inactivation of CDKs in nocodazole-arrested cells can
induce the reaccumulation of Mcm2–7 in the nucleus,
and ectopic expression of stable Clb2 (M-CDK) in G1-
arrested cells causes redistribution of free Mcm2–7 to
the cytoplasm [14,15], indicating that the nuclear
localisation of Mcm2–7 is regulated by CDKs.
The regulation of Cdt1 in S. cerevisiae is intimately
connected to that of Mcm2–7. Cdt1 protein levels are
approximately constant throughout the budding yeast
cell cycle. Like Mcm2–7, however, the subcellular
localisation of Cdt1 is regulated so that it is nuclear in
G1 and cytoplasmic later in the cell cycle [16]. Free
Mcm2–7 is bound to Cdt1 and, in the absence of
Cdt1, Mcm2–7 does not accumulate in the nucleus
during G1 phase. Conversely, Cdt1 does not accumu-
late in the nucleus in the absence of Mcm2–7.
Moreover, addition of the SV40 TAg NLS onto Mcm7
(Mcm7–SV40 NLS) causes constitutive nuclear
localisation of both Mcm2–7 [14] and Cdt1 [16].
The phosphorylation of two ORC subunits, Orc2
and Orc6, also contributes to preventing re-replica-
tion. The mechanism of ORC inactivation by CDK
phosphorylation is presently not known, but presum-
ably does not affect its DNA binding activity as ORC is
bound at origins in vivo throughout the cell cycle
[17–19]. Recently it has been shown that the S-CDK,
Clb5, is specifically recruited to ORC at origins by
virtue of interaction with an ‘RXL’ motif within Orc6
[20], where it contributes to preventing re-replication.
Re-replication is induced in G2/M-arrested cells
expressing a stabilized version of Cdc6 together with
Mcm7–SV40 NLS and mutant forms of Orc2 and Orc6
that lack CDK consensus sites [21]. All three proteins
— Cdc6, Mcm2-7 and ORC — must be de-regulated
in order to induce substantial re-replication. Thus, the
regulation of Cdc6, Mcm2-7 (with Cdt1) and ORC all
contribute to preventing re-replication.
Fission Yeast
The cell cycle of the fission yeast Schizosaccharomyces
pombe is characterised by a short G1 phase and a long
G2 phase, during which most growth control occurs. G1
phase is so short that, when grown in rich medium, DNA
replication begins prior to cytokinesis. Nonetheless, this
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Figure 1. Cell cycle regulation.
The main cell cycle regulators involved in
DNA replication control are shown. Details
of the individual steps are indicated by



































G1 phase has more similarities to the longer G1 phases
of budding yeast and metazoan somatic cells than to
the short G1 phases of metazoan early embryos. Tran-
scription and protein synthesis are required for G1
transit, and cells can be arrested during G1 phase by
mating pheromone and nutrient starvation.
The first experiments indicating that CDKs have a
role in preventing re-replication in any eukaryotic
organism came from experiments in fission yeast.
Conditions which cause depletion of M-CDK, includ-
ing deletion of the mitotic cyclin, cdc13+ [22], overex-
pression of the CKI rum1+ [23] or heat shock of a cdk1
(cdc2+) temperature-sensitive mutant [24], all induce
re-replication.
Early efforts to understand once-per-cell-cycle
replication focused on the Cdc6 ortholog (cdc18+)
because its overexpression induces re-replication
[25,26]. CDKs were implicated in this control because
cdc18+ mutants lacking CDK consensus sites were
more efficient than wild-type cdc18+ at inducing re-
replication [27,28]. Like budding yeast Cdc6,
S. pombe cdc18+ is an unstable protein and proteoly-
sis of cdc18+ is directed by two Cdc4 homologs,
pop1+ and pop2+/sud1+ [29–32]. CDK phosphorylation
is required for interaction of pop1 and pop2 with
cdc18+ [32], and CDK phosphorylation site mutants of
cdc18+ are more stable than wild-type cdc18+ [28],
indicating that, as in budding yeast, phosphorylation
of cdc18+ is required for recognition by SCF. 
Because overexpression of Cdc6 in budding yeast
does not induce re-replication, these results initially
made the block to re-replication in fission yeast seem
‘simpler’, as perhaps cdc18+ was the main target of
CDK inhibition. Subsequent analysis, however, has
uncovered a similar complexity in replication control
in fission yeast to that in budding yeast, which was
probably masked in some way by the overexpression
of cdc18+ [33,34].
Whereas Cdt1 is co-regulated with Mcm2–7 in
budding yeast, in fission yeast, cdt1+ is co-regulated
with cdc18+. Like cdc18+, cdt1+ protein levels
fluctuate during the cell cycle, peaking in late mitosis
and gradually disappearing during S phase [34]. This
is partly because cdc18+ and cdt1+ are both targets of
the cell-cycle transcription factor cdc10+, responsible
for M/G1 transcription [35,36]. The mechanism of Cdt1
proteolysis has not yet been investigated.
The S. pombe ortholog of Orc2 (orp2+) is phosphory-
lated by CDKs in vivo, and orp2 mutants lacking CDK
consensus sites allow more re-replication to occur in
cells overexpressing cdc18+ [37]. The mitotic cyclin
cdc13+ has been localized to origins by chromatin
immunoprecipitation, and cells expressing a tagged
orp2+ were partially defective in cdc13+ origin binding
and hypersensitive to cdc18+-induced re-replication
[38]. Thus, ORC, cdt1+ and cdc18+ all appear to con-
tribute to preventing re-replication in S. pombe.
Xenopus
The early embryonic divisions in the frog Xenopus
laevis are somewhat simpler than the yeast cell cycles
described above: there is no discrete G1 phase, the
cell cycle is uncoupled from growth and various cell
cycle ‘checkpoints’ are absent. APC/CCdc20 is the
dominant form of the APC/C — the Cdh1 ortholog
appears to be absent in these early cell cycles [39].
Additionally, although a Xenopus CKI has been identi-
fied [40,41], its levels in early embryos are too low to
be effective in inhibiting CDKs [40].
McGarry and Kirschner [42] identified geminin in a
screen for APC/C substrates in Xenopus. Like cyclins,
geminin has a destruction box which is required for its
ubiquitylation and degradation in vitro by APC/C.
Addition of recombinant geminin blocked DNA
replication by preventing licensing. Specifically, the
loading of ORC and Cdc6 proceeded normally in the
presence of stable geminin, but the Mcm2–7 complex
was not loaded [42]. Subsequent work has shown that
geminin inhibits licensing by binding to and inactivat-
ing Cdt1 [43,44]. These experiments established
geminin as both an APC/C substrate and a licensing
inhibitor. In contrast to exogenously added recombi-
nant geminin, endogenous geminin is not degraded
efficiently at the end of mitosis [45,46]. Instead,
APC/C-dependent ubiquitylation appears sufficient to
inhibit geminin function [45,47]. The small molecule
CDK inhibitor 6-dimethyl aminopurine (6-DMAP)
blocks licensing when added to metaphase-arrested
Xenopus extracts [48]. Because Cdc20 can only acti-
vate the form of APC/C that is hyper-phosphorylated
by M-CDK (Figure 1), 6-DMAP inhibits licensing by
preventing APC/CCdc20 activation and consequent
geminin inactivation [47].
APC/C-dependent inhibition of geminin is not the
only mechanism for preventing re-replication in
Xenopus egg extracts, because immunodepletion of
geminin does not induce extensive re-replication [42].
Depletion of geminin in mitotic extracts only partially
restores licensing function. Treatment of this geminin-
depleted extract with 6-DMAP or roscovitine results in
full restoration of licensing activity [44], suggesting
that, in addition to promoting licensing via geminin
degradation, CDKs also inhibit licensing by an addi-
tional mechanism. Addition of excess Cdt1 to
geminin-depleted extracts also restored full licensing
activity suggesting that this additional CDK-depen-
dent mechanism may work through Cdt1 [44].
Cdc6 is displaced from nuclei by CDKs; however,
Cdc6 mutants in which all CDK consensus sites have
been eliminated are not exported yet still support
once-per-cell-cycle replication [49]. It has recently
been shown that there are two isoforms of Cdc6 in
Xenopus: one, Xcdc6A, is embryonic, disappearing
after the mid-blastula transition (MBT); the other,
Xcdc6B, is present but non-functional in embryos, but
essential in somatic cells [50]. It will be interesting to
see if the somatic Cdc6 is regulated differently from
the embryonic form.
Drosophila
The fruitfly Drosophila and distantly related dipteran
Sciara coprophila have been especially useful in
understanding replication control in cells that disobey
the ‘once per cell cycle’ paradigm as part of their
developmental program. These include cells undergo-
ing multiple rounds of endoreduplication — for
example, nurse cells, follicle cells and cells in a variety
of larval tissues — as well as cells undergoing
localized, programmed gene amplification — for
example, the chorion gene cluster in follicle cells.
These localized amplification events occur from
discrete origins [51–53], require specific DNA
sequences [54] and the same replication components
which are involved in normal chromosomal DNA
replication [53,55–59].
A Drosophila geminin homolog interacts with Cdt1,
the product of the dup locus [60]. Overexpression of
this geminin homolog inhibits replication, while its
depletion induces some over-replication in certain
endoreduplicating cells and induces prolonged
periods of DNA synthesis in follicle cells, presumably
reflecting overamplification of the chorion genes [60].
Reduction of geminin by siRNA in a Drosophila
embryonic cell line also resulted in an increase in
ploidy [61].
The APC/C plays an additional and somewhat
confusing role in regulating DNA replication in
Drosophila by targeting the largest subunit of ORC, Orc1
for degradation [62]. The apparently contradictory activ-
ities of the APC/C in eliminating inhibitors of licensing
(geminin and cyclins) and activators of licensing (Orc1)
are also seen in mammalian cells (see below).
During Drosophila development, cells exit the cell
cycle after mitosis 16 (M16) and remain quiescent for
long periods of time. Unlike earlier cell cycles,
Mcm2–7 does not associate with chromatin after M16
[63], suggesting that these cells prepare for
quiescence prior to mitosis. This differs from budding
yeast and mammalian tissue culture cells which, at
least under certain conditions, assemble pre-RCs at
the end of mitosis and disassemble them upon entry
into quiescence [17,64–66]. 
The Drosophila CKI encoded by the dacapo (dap)
gene is expressed just prior to M16 and is required for
the withdrawal of cells from the cell cycle after M16
[67]. Consistent with this, Mcm2–7 becomes associ-
ated with chromosomes after M16 in dap mutants and
these mutants then undergo an additional round of
replication [63]. Dap is an inhibitor of cyclin E–cdk2,
and ectopic expression of cyclin E in Drosophila
endocycles can induce Mcm chromatin association
[68]. These results indicate that cyclin E has a positive
role in licensing. It has also been shown, however, that
continuous expression of cyclin E prevents endoredu-
plication [69,70], consistent with the idea that cyclin E
can also inhibit licensing. The role of cyclin E in
regulating licensing is discussed below.
Mammals
Geminin levels fluctuate during the cell cycle in HeLa
cells: geminin is absent during G1 phase and accu-
mulates during S, G2 and M phases, consistent with
the idea that it is an APC/C substrate [42]. Depletion
of geminin by siRNA in human tissue culture cells
induces some re-replication [71], indicating that
geminin plays a critical role in replication control.
Similar to the situation in Drosophila, in mammals
the APC/C plays an additional and somewhat
contradictory role in regulating pre-RC assembly.
Cdc6 is absent from early G1 and quiescent cells in
many (but not all) cell lines [64,72,73]. Overexpression
of Cdh1 is sufficient to induce Cdc6 degradation in
human cells [72], suggesting that APC/CCdh1 is most
important in regulating Cdc6 proteolysis. It is
presently unclear how the APC/C-dependent degra-
dation of a licensing inhibitor (geminin) and a licensing
activator (Cdc6) are coordinated to ensure efficient
pre-RC assembly.
CDKs also appear to play a role in inhibiting
inappropriate pre-RC assembly. Elimination of M-CDK
activity by deleting the Cdc2 (CDK1) gene induces
multiple rounds of endoreduplication [74]. Moreover,
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Figure 2. A general view of pre-RC regulation.
(A) The APC/C acts to remove inhibitors of pre-RC assembly,
including cyclins and geminin. CKIs can also contribute to CDK
inhibition. CDKs generally inhibit most or all pre-RC compo-
nents, while geminin is a Cdt1 inhibitor specifically found in
metazoans. (B) In yeast, geminin is absent and regulation
occurs entirely through CDKs. (C) In metazoans, Geminin is
especially important, while CDKs may play a lesser role, at least
in some cell types.
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when CDKs are inhibited in G2, either by treatment of
cells with 6-DMAP or genetic ablation of CDK1,
Mcm2-7 rebinds and chromatin is re-licensed [75–77].
It is interesting that CDK inhibition in G2 HeLa cells
(as well as yeast) promotes licensing, while CDK
inhibition in Xenopus egg extracts inhibits licensing.
Although it is unlikely, geminin may already be inactive
in these G2 HeLa cells. A more interesting possibility
is that CDK inhibition may inactivate geminin by
promoting activation of APC/CCdh1. As Cdh1 appears
to be absent from egg extracts, 6-DMAP could not
activate APC/CCdh1 in this situation and geminin might
be stabilized.
Several potential CDK targets have been identified
in mammalian cells. In addition to being an APC/C
substrate, Cdc6 can also be targeted for proteolysis
by cyclin A–CDK2 [78]. This proteolysis only affects
soluble forms of Cdc6, while forms that are bound to
chromatin persist through S and G2 phases
[64,73,78,79]. CDKs can also regulate the nuclear
localisation of ectopically expressed Cdc6 [80–83],
which is nuclear in G1 phase but redistributes to the
cytoplasm in S and G2 phases. This relocalisation
requires CDK sites in the amino terminus of Cdc6.
Expression of cyclin A (but not cyclin E) induces relo-
calisation. Thus, the pool of Cdc6 which is not bound
to chromatin may be targeted for proteolysis and/or
nuclear export by CDKs.
CDKs regulate Cdt1 via two distinct mechanisms.
First, CDKs target Cdt1 for proteolysis via SCFSkp2
[84–86] and second, CDKs inhibit a novel DNA binding
activity of Cdt1 [85]. Neither of these mechanisms
require geminin. The binding of geminin to Cdt1 has
been reported to inhibit Cdt1’s DNA binding activity
[87], though in Xenopus geminin does not interfere
with Cdt1 chromatin association and is actually
recruited to chromatin by Cdt1 [46,88]. CDK inactiva-
tion in G2 promotes the re-accumulation of Cdt1 on
chromatin [85] and overexpression of Cdt1 together
with Cdc6 induces re-replication [89].
ORC may also be regulated by CDKs [90]. While
Orc2–6 (together with Cdc6) remain bound to
chromatin during G1, S and G2 phases, the Orc1
subunit is released from chromatin during S phase
[91–93]. In one study [92] examining ORC in human
cells, Orc1 was degraded in a SCFSkp2-dependent
manner which presumably requires CDK phosphory-
lation of ORC. In a second study [93] using a hamster
cell line, Orc1 was not degraded, but instead was
released from chromatin during S phase when it accu-
mulated as either a monoubiquitinylated or diubiqui-
tinylated form. Yet another study [65] suggested that
Orc1 remains chromatin bound throughout the cell
cycle. Whether these differences are related to differ-
ences in experimental design or reflect cell line differ-
ences has not been resolved. Finally, overexpression
of cyclin A or K cyclin from Kaposi sarcoma-associ-
ated herpesvirus induces the relocalisation of Orc1 to
the cytoplasm [94]. So, perhaps like Cdc6, free Orc1
can be either degraded or exported (or both) in a
CDK-dependent manner.
As in Drophila, cyclin E plays an enigmatic role in
regulating DNA replication in mammalian cells. Neither
cyclin E nor CDK2 are essential for mouse develop-
ment — apart from being required for development of
extraembryonic tissues — arguing against any
essential role for cyclin E in regulating replication in
the mitotic cell cycle [95–97]. However, cyclin E defi-
ciency causes two specific DNA replication defects;
cells re-entering the cell cycle from quiescence fail to
load Mcm2-7 and endoreplication in trophoblast giant
cells and megakaryocytes is impaired [96,97]. 
These results indicate that cyclin E plays a positive
role in licensing in specific situations, consistent with
in vitro studies [98]. One potential role for cyclin E in
licensing is probably activation of the E2F transcription
factor. Several pre-RC components including Cdc6,
Cdt1 and Orc1 as well as the inhibitor geminin are E2F
targets [99–102]. Of these, Cdc6 appears to be most
important since forced Cdc6 expression in quiescent
cells is sufficient to drive Mcm2–7 loading [103].
Redundancy and Rapid Evolution: Hallmarks of
Pre-RC Regulation
Three general principles can be gleaned from the
discussion above. First, the assembly of pre-RCs is
restricted to a period of high APC/C and low CDK
activity. APC/C promotes pre-RC assembly by elimi-
nating cyclins and, in metazoans, geminin (Figure 2).
Second, pre-RC assembly is generally inhibited by
multiple mechanisms. Virtually every conceivable way
of inhibiting pre-RC components is used: proteolysis,
nuclear export and inhibitor binding. And third,
mechanisms by which individual pre-RC components
are inhibited are quite different in different organisms,
indicating a high degree of evolutionary plasticity.
One of the main reasons for employing multiple
strategies to inhibit licensing is probably that prevent-
ing re-initiation is crucial for maintaining genome
integrity. If just one out of 50,000 potential origins in a
human cell were to re-fire during a single cell cycle,
this could have grave consequences for a cell. Con-
sequently, being 99.998% efficient at preventing inap-
propriate pre-RC assembly is not good enough! If this
were the only reason, however, one might expect
organisms with larger genomes and larger numbers of
origins to have additional levels of regulation. Instead,
the block to re-replication appears to be as compli-
cated in yeast as it is in human cells, suggesting that
there may be additional reasons for some of the com-
plexity. In budding yeast, pre-RCs can only assemble
during G1 phase because CDKs are active during the
remainder of the cell cycle, when they inhibit Cdc6,
Mcm2-7 and ORC; CDK activation then promotes
origin firing. 
This idea that replication is regulated by oscillation
between two mutually exclusive states is diagrammed
in Figure 3A. Although elegant in its simplicity and fun-
damentally correct, this scheme has an inherent
design weakness. During the transitions between high
and low CDK activity there is potential for misregula-
tion at intermediate CDK levels. For example, as cells
activate CDKs at the end of G1 phase, there is a risk
that an origin might fire at a CDK level too low to
prevent re-licensing. Such an origin might, therefore,
re-licence and fire for a second time in one S phase.
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Likewise, as CDKs are inactivated at the end of
mitosis, there is a risk that at some intermediate CDK
level, some pre-RCs may assemble. If a small number
of pre-RCs were to assemble in the presence of CDK
activity, there would be a risk of initiating replication
from these pre-RCs before mitosis ends. There would
then be nothing to prevent this origin from being re-
licensed during the following low CDK G1 phase and
re-firing during S phase.
Closer examination of the way pre-RC components
are regulated suggests how this problem is avoided in
yeast (Figure 3B). Firstly, two key S phase promoting
factors, Clb5 (the S phase cyclin) and Dbf4 (the regu-
latory subunit of the Cdc7 protein kinase), are both
APC/C substrates. Both are degraded at the
metaphase–anaphase transition and both are absent
from cells arrested in late mitosis by mutation in the
MEN. This is because Clb5, and presumably Dbf4, are
APC/CCdc20 targets [104–107]. However, pre-RCs have
not yet assembled at origins in cells arrested with any
MEN mutants [17], because the M-CDK, Clb2–CDK1,
is still present and active and is not degraded until
APC/CCdh1 is activated. Although Clb2 can prevent
pre-RC assembly, it is very poor at activating origin
firing [108]. Thus, during mitosis, S phase promoting
factors are degraded before, not concomitant with,
pre-RC assembly (Figure 3B).
Similarly, at the end of G1 phase, pre-RC compo-
nents are inactivated by the G1 cyclins, Cln1/Cln2
[9,15]. Again, this occurs before, not concomitant with,
the activation of the S-phase-promoting factors Dbf4
and Clb5. Consequently, in budding yeast, pre-RC
assembly is kept completely separate from origin
firing because Clb2 and Cln1/Cln2, which can both
inhibit licensing but cannot promote S phase, provide
‘insulation’ at both ends of G1. The G1 cyclins only
inhibit Cdc6 and Mcm2–7, not ORC, so only a subset
of the pathways are involved in providing this insula-
tion at the end of G1 phase.
Because preventing re-replication is so fundamen-
tal to genome stability and cell cycle control, one
might have expected that mechanisms involved in
regulating pre-RC assembly would have arisen once
at an early stage in eukaryotic cell evolution and then
been conserved from that point on. At the upper-most
level of regulation this is true — in all organisms that
have been studied, pre-RC assembly is limited to a
period of high APC/C and low CDK activity, and CDKs
contribute to the inhibition of pre-RC assembly. It has,
however, been surprising to see that pre-RC compo-
nents are regulated so differently in different organ-
isms, implying rapid evolution of the regulatory
pathways downstream of APC/C and CDKs [109].
The significant overlap of pathways in preventing
pre-RC assembly probably provides the means for
rapid evolution. No single pathway in budding yeast —
for example cell-cycle-regulated transcription of pre-
RC components, Cdc6 stabilization, Mcm2–7 nuclear
localisation, ORC phosphorylation — is essential for
viability, and so any one might easily be lost in evolu-
tion. Presumably, at some point, further loss of path-
ways would be detrimental and may provide the drive
to establish new pathways.
While redundancy may provide the means for
change, what is less clear is whether the different
regulation seen in different cells has any deeper
significance. It is likely that differences in cell cycles
may require different types of regulation. For example,
in early metazoan embryos, the first divisions occur
without transcription, eliminating one level of potential
regulation. Additionally, differences in the regulation of
quiescence in different cell types may be important in
understanding differences in pre-RC regulation. It may
be more important for metazoans to ensure that pre-
RCs do not assemble at origins in cells during quies-
cence, as the quiescent state may need to be
maintained for many years. Whereas reassembly of
pre-RCs upon re-entry into the cell cycle appears to be
straightforward in budding yeast, because Cdc6 and
Mcm2–7 are re-synthesized prior to the synthesis of the
G1 cyclins [110], the same does not appear to be true
in mammalian cells, where licensing in mitosis differs
from that in cells re-entering the cell cycle from quies-
cence in the requirement for cyclin E (see above).
Another factor that may contribute to differences in
regulation relates to the fact that many pre-RC proteins
also play roles outside of DNA replication. The nature
of these additional functions may place restrictions on
how they can be regulated. For example, the Orc1
subunit plays a central role in transcriptional silencing
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Figure 3. Pre-RC regulation by CDKs.
(A) A hypothetical model for pre-RC regu-
lation. In this simplest view, CDKs can
both inhibit assembly of new pre-RCs and
activate replication origins with existing
pre-RCs. Drawbacks of this two state
model are described in the text.
(B) Regulation of replication in budding
yeast. Pre-RC assembly is kept separate
from origin activation by the G1-CDKs
and M-CDKs which can prevent pre-RC
assembly but cannot trigger origin firing
(see text for details).
META ANA/TEL G1 START S G2 META
Pre-RC assembly Origin activation potential
A
CDKs: Pre-RC inhibition/origin activation
META G1 START S G2 META
S-CDK and DDK
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of the mating type genes in budding yeast [111,112].
Although it has not been tested directly, Orc1 may
need to remain bound at silencers throughout the
entire cell cycle to execute its silencing function which
would be incompatible with the regulation of Orc1 by
displacement from the ORC complex, as seen in mam-
malian cells. 
Several replication proteins have been shown to
have roles in mitosis. The Orc6 subunit is involved in
cytokinesis in both Drosophila and mammalian cells
[113,114] and the fission yeast Cdc7 homolog, hsk1+,
is required for centromeric cohesion [115]. Addition-
ally, Mcm2–7 has been implicated in transcriptional
control [116–120], Cdc6 has been implicated in
checkpoint regulation [121–123] and geminin has roles
during development that appear to be separable from
its role in regulating replication [60,124–126]. Each of
these non-replication functions may place constraints
on when and where active protein must be present
and, consequently, may limit the way in which they
can be inhibited.
Finally, a great deal of the discussion above has
emphasized differences in pre-RC regulation between
different organisms. However, it should be empha-
sized that even within a single organism, different
mechanisms of regulation act in different cell types.
Examples include the lack of APC/CCdh1 in early
embryos, the two isoforms of Xenopus Cdc6
expressed during development and the role of cyclin
E in a subset of cell types. It is likely that the next few
years will see many more examples like these uncov-
ered. Exploitation of such differences may provide
some novel approaches to specifically inhibit prolifer-
ation in cancer cells.
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